期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | VIRCHOWS ARCHIV LetPub Score 6.4
50 ratings
Rate
Reputation 7.6 Influence 5.2 Speed 7.1 | ||||||||||||||||||||||||
期刊簡稱 | VIRCHOWS ARCH | ||||||||||||||||||||||||
ISSN | 0945-6317 | ||||||||||||||||||||||||
E-ISSN | 1432-2307 | ||||||||||||||||||||||||
h-index | 90 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 2.90%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://www.springer.com/428 | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/viar | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Springer Berlin Heidelberg | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | GERMANY | ||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||
創刊年 | 1847 | ||||||||||||||||||||||||
每年文章數 | 196每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 37.72% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0945-6317%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[VIRCHOWS ARCHIV] 的評論 | 撰寫評論 |
作者: 无名氏GD 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-27 13:28:20 評論於 Does this magazine accept submissions? Where can I find the submission guidelines?(0) 讚! | 无名氏GD |
作者: 岭南访松 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-24 23:53:20 評論於 Submission requires tex format. I have no idea how to do it.(0) 讚! | 岭南访松 |
作者: chengchenga 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-01-28 10:05:46 評論於 Prompt manuscript processing, meticulous reviewers, and fair feedback! 10.31 Submitted to the journal 11.1 With editor 11.7 Under Review 11.22 Required Reviews Completed 11.23 Decision in process 11.24 Major revision 12.8 Revision submitted to the journal 12.12 With editor 12.16 Under Review 12.27 Required Reviews Completed 1.4 Minor revision 1.14 Revision Submitted to Journal 1.16 With editor 1.24 Decision in process 1.27 Accept(0) 讚! | chengchenga |
作者: Norma Wilmott 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-27 18:37:49 評論於 The manuscript was handled very quickly, the reviewers were very careful, and the suggestions were very constructive! 10.31 Submitted to the journal 11.1 With editor 11.7 Under Review 11.22 Required Reviews Completed 11.23 Decision in process 11.24 Major revision 12.8 Revision submitted to the journal 12.12 With editor 12.16 Under Review 12.27 Required Reviews Completed 1.4 Minor revision 1.14 Revision Submitted to Journal 1.16 With editor 1.24 Decision in process 1.27 Accept(0) 讚! | Norma Wilmott |
作者: Norma Wilmott 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-27 14:52:09 評論於 Review speed: 3.0 | Submission hit rate: 50.0 Emphasized research direction: Pathological morphology Experience sharing: The manuscript processing is very fast, the reviewers are very serious, and the suggestions are very pertinent 10.31 Submitted to the journal 11.1 With editor 11.7 Under Review 11.22 Required Reviews Completed 11.23 Decision in process 11.24 Major revision 12.8 Revision submitted to the journal 12.12 With editor 12.16 Under Review 12.27 Required Reviews Completed 1.4 Minor revision 1.14 Revision Submitted to Journal 1.16 With editor 1.24 Decision in process 1.27 Accept(0) 讚! | Norma Wilmott |
作者: Norma Wilmott 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-27 12:31:19 評論於 10.31 Submitted to the journal 11.1 With editor 11.7 Under Review 11.22 Required Reviews Completed 11.23 Decision in process 11.24 Major revision 12.8 Revision submitted to the journal 12.12 With editor 12.16 Under Review 12.27 Required Reviews Completed 1.4 Minor revision 1.14 Revision submitted to Journal 1.16 With editor 1.24 Decision in process 1.27 Accept(0) 讚! | Norma Wilmott |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:35:35 評論於 The introduction should outline the challenges you want to address and the questions you want to answer, summarizing existing research and gaps in knowledge(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 19:27:54 評論於 Introduction writing focuses on proposing the unresolved problems and the innovative or valuable aspects of one's research. Discussion section requires in-depth comparison and analysis of one's research results with previous findings. The emphasis is different between the two(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 17:01:02 評論於 Introduction and discussion are different in how they are written(0) 讚! | 陶宜三岁啦 |
作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 17:08:35 評論於 How to write an introduction? Different from discussion?(0) 讚! | 魂魄彦露 |
作者: 谷蓝大叔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-09-23 18:57:53 評論於 In classic pathology journals, there are few articles written by Chinese authors. Not good(0) 讚! | 谷蓝大叔 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us